Alessandra G. Buma
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Clinical validation and implementation of mSTOP, a machine learning-based, longitudinal prediction model for the early identification of non-small cell lung cancer patients who not benefit from immune checkpoint inhibitor treatment.
Journal: Clinical chemistry and laboratory medicine
Published: December 05, 2025
Serological Response Patterns to Assess Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Multi-Center Observational Cohort Study.
Journal: Cancers
Published: September 10, 2025
Dosing, duration, and timing controversies in determining immune checkpoint inhibitor dosing regimens.
Journal: NPJ precision oncology
Published: August 07, 2025
No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjects.
Journal: International journal of cancer
Published: June 05, 2025
Reply to Letter to the Editor "Lung cancer detection by electronic nose analysis of exhaled breath: a multi-center prospective external validation study" by Liu et al., G. Rocco, and Szarpak et al.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 06, 2025
Lung cancer detection by electronic nose analysis of exhaled breath: a multicentre prospective external validation study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 23, 2025
Very Early Health Technology Assessment for Potential Predictive Biomarkers in the Treatment of Advanced Non-Small Cell Lung Cancer.
Journal: PharmacoEconomics - open
Published: January 05, 2025
Follow-up after first-Line nivOlumab plus ipilimumab in patients with diffuse pleuRal mesotheliomA: a real-world Dutch cohort study-FLORA.
Journal: ESMO open
Published: September 26, 2024
Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancer.
Journal: Frontiers in pharmacology
Published: August 08, 2023
Appraisal of the PathoDiscovery: an interactive web-based educational tool for teaching pathophysiology and histopathology.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: May 24, 2023
Clinical perspectives on serum tumor marker use in predicting prognosis and treatment response in advanced non-small cell lung cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: January 30, 2023
Last Updated: 09/26/2026